nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—Blood bilirubin increased—Sorafenib—liver cancer	0.0289	0.0297	CcSEcCtD
Cefadroxil—Prothrombin level increased—Epirubicin—liver cancer	0.0246	0.0253	CcSEcCtD
Cefadroxil—Prothrombin level increased—Doxorubicin—liver cancer	0.0228	0.0234	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Sorafenib—liver cancer	0.0227	0.0233	CcSEcCtD
Cefadroxil—Hepatic failure—Sorafenib—liver cancer	0.0221	0.0227	CcSEcCtD
Cefadroxil—Lactic dehydrogenase activity increased—Epirubicin—liver cancer	0.0197	0.0203	CcSEcCtD
Cefadroxil—Lactic dehydrogenase activity increased—Doxorubicin—liver cancer	0.0183	0.0187	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.0179	0.0183	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.0179	0.0183	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Sorafenib—liver cancer	0.0175	0.018	CcSEcCtD
Cefadroxil—Blood lactate dehydrogenase increased—Epirubicin—liver cancer	0.0174	0.0178	CcSEcCtD
Cefadroxil—Blood lactate dehydrogenase increased—Doxorubicin—liver cancer	0.0161	0.0165	CcSEcCtD
Cefadroxil—Neutropenia—Sorafenib—liver cancer	0.016	0.0165	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.0152	0.0156	CcSEcCtD
Cefadroxil—Haemoglobin—Sorafenib—liver cancer	0.0138	0.0142	CcSEcCtD
Cefadroxil—Haemorrhage—Sorafenib—liver cancer	0.0137	0.0141	CcSEcCtD
Cefadroxil—Erythema multiforme—Sorafenib—liver cancer	0.013	0.0133	CcSEcCtD
Cefadroxil—Muscle spasms—Sorafenib—liver cancer	0.0115	0.0118	CcSEcCtD
Cefadroxil—Angioedema—Sorafenib—liver cancer	0.0109	0.0112	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Epirubicin—liver cancer	0.0107	0.011	CcSEcCtD
Cefadroxil—Creatinine increased—Epirubicin—liver cancer	0.0106	0.0109	CcSEcCtD
Cefadroxil—Arthralgia—Sorafenib—liver cancer	0.0102	0.0104	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Epirubicin—liver cancer	0.0101	0.0104	CcSEcCtD
Cefadroxil—Vaginal inflammation—Epirubicin—liver cancer	0.0101	0.0104	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Doxorubicin—liver cancer	0.00988	0.0101	CcSEcCtD
Cefadroxil—Creatinine increased—Doxorubicin—liver cancer	0.00982	0.0101	CcSEcCtD
Cefadroxil—Anaphylactic shock—Sorafenib—liver cancer	0.00975	0.01	CcSEcCtD
Cefadroxil—Thrombocytopenia—Sorafenib—liver cancer	0.00955	0.0098	CcSEcCtD
Cefadroxil—Blood urea increased—Epirubicin—liver cancer	0.00954	0.00979	CcSEcCtD
Cefadroxil—Vaginal infection—Epirubicin—liver cancer	0.00954	0.00979	CcSEcCtD
Cefadroxil—Aplastic anaemia—Epirubicin—liver cancer	0.00948	0.00974	CcSEcCtD
Cefadroxil—Vaginal inflammation—Doxorubicin—liver cancer	0.00935	0.00959	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.00935	0.00959	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00888	0.00912	CcSEcCtD
Cefadroxil—Blood urea increased—Doxorubicin—liver cancer	0.00882	0.00906	CcSEcCtD
Cefadroxil—Vaginal infection—Doxorubicin—liver cancer	0.00882	0.00906	CcSEcCtD
Cefadroxil—Aplastic anaemia—Doxorubicin—liver cancer	0.00877	0.00901	CcSEcCtD
Cefadroxil—Dyspepsia—Sorafenib—liver cancer	0.00858	0.00881	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00843	0.00865	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Sorafenib—liver cancer	0.00842	0.00864	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Epirubicin—liver cancer	0.00839	0.00861	CcSEcCtD
Cefadroxil—Hepatic failure—Epirubicin—liver cancer	0.00816	0.00838	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Sorafenib—liver cancer	0.00797	0.00819	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.0078	0.00801	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Doxorubicin—liver cancer	0.00776	0.00797	CcSEcCtD
Cefadroxil—Urticaria—Sorafenib—liver cancer	0.00775	0.00795	CcSEcCtD
Cefadroxil—Abdominal pain—Sorafenib—liver cancer	0.00771	0.00791	CcSEcCtD
Cefadroxil—Body temperature increased—Sorafenib—liver cancer	0.00771	0.00791	CcSEcCtD
Cefadroxil—Hepatic failure—Doxorubicin—liver cancer	0.00755	0.00775	CcSEcCtD
Cefadroxil—Hypersensitivity—Sorafenib—liver cancer	0.00718	0.00738	CcSEcCtD
Cefadroxil—Asthenia—Sorafenib—liver cancer	0.007	0.00718	CcSEcCtD
Cefadroxil—Pruritus—Sorafenib—liver cancer	0.0069	0.00708	CcSEcCtD
Cefadroxil—Blood creatinine increased—Epirubicin—liver cancer	0.00687	0.00705	CcSEcCtD
Cefadroxil—Diarrhoea—Sorafenib—liver cancer	0.00667	0.00685	CcSEcCtD
Cefadroxil—Cefpiramide—ALB—liver cancer	0.00662	0.256	CrCbGaD
Cefadroxil—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.0066	0.00678	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.0066	0.00678	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00647	0.00664	CcSEcCtD
Cefadroxil—Dizziness—Sorafenib—liver cancer	0.00645	0.00662	CcSEcCtD
Cefadroxil—Blood creatinine increased—Doxorubicin—liver cancer	0.00636	0.00652	CcSEcCtD
Cefadroxil—Eosinophilia—Epirubicin—liver cancer	0.00627	0.00644	CcSEcCtD
Cefadroxil—Vomiting—Sorafenib—liver cancer	0.0062	0.00636	CcSEcCtD
Cefadroxil—Rash—Sorafenib—liver cancer	0.00615	0.00631	CcSEcCtD
Cefadroxil—Dermatitis—Sorafenib—liver cancer	0.00614	0.00631	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00611	0.00627	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00611	0.00627	CcSEcCtD
Cefadroxil—Headache—Sorafenib—liver cancer	0.00611	0.00627	CcSEcCtD
Cefadroxil—Pancytopenia—Epirubicin—liver cancer	0.00602	0.00618	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00598	0.00614	CcSEcCtD
Cefadroxil—Neutropenia—Epirubicin—liver cancer	0.00593	0.00608	CcSEcCtD
Cefadroxil—Eosinophilia—Doxorubicin—liver cancer	0.00581	0.00596	CcSEcCtD
Cefadroxil—Nausea—Sorafenib—liver cancer	0.00579	0.00595	CcSEcCtD
Cefadroxil—Cefonicid—ALB—liver cancer	0.00576	0.223	CrCbGaD
Cefadroxil—Drowsiness—Epirubicin—liver cancer	0.00565	0.0058	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.0056	0.00575	CcSEcCtD
Cefadroxil—Pancytopenia—Doxorubicin—liver cancer	0.00557	0.00572	CcSEcCtD
Cefadroxil—Neutropenia—Doxorubicin—liver cancer	0.00548	0.00563	CcSEcCtD
Cefadroxil—Agranulocytosis—Epirubicin—liver cancer	0.00527	0.00541	CcSEcCtD
Cefadroxil—Drowsiness—Doxorubicin—liver cancer	0.00523	0.00537	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00518	0.00532	CcSEcCtD
Cefadroxil—Haemoglobin—Epirubicin—liver cancer	0.0051	0.00523	CcSEcCtD
Cefadroxil—Haemorrhage—Epirubicin—liver cancer	0.00507	0.00521	CcSEcCtD
Cefadroxil—Agranulocytosis—Doxorubicin—liver cancer	0.00488	0.00501	CcSEcCtD
Cefadroxil—Erythema multiforme—Epirubicin—liver cancer	0.0048	0.00492	CcSEcCtD
Cefadroxil—Haemoglobin—Doxorubicin—liver cancer	0.00472	0.00484	CcSEcCtD
Cefadroxil—Haemorrhage—Doxorubicin—liver cancer	0.00469	0.00482	CcSEcCtD
Cefadroxil—Erythema multiforme—Doxorubicin—liver cancer	0.00444	0.00456	CcSEcCtD
Cefadroxil—Tension—Epirubicin—liver cancer	0.00433	0.00445	CcSEcCtD
Cefadroxil—Nervousness—Epirubicin—liver cancer	0.00429	0.0044	CcSEcCtD
Cefadroxil—Muscle spasms—Epirubicin—liver cancer	0.00425	0.00436	CcSEcCtD
Cefadroxil—Tension—Doxorubicin—liver cancer	0.00401	0.00412	CcSEcCtD
Cefadroxil—Nervousness—Doxorubicin—liver cancer	0.00397	0.00407	CcSEcCtD
Cefadroxil—Vertigo—Epirubicin—liver cancer	0.00397	0.00407	CcSEcCtD
Cefadroxil—Muscle spasms—Doxorubicin—liver cancer	0.00393	0.00403	CcSEcCtD
Cefadroxil—Convulsion—Epirubicin—liver cancer	0.00383	0.00393	CcSEcCtD
Cefadroxil—Arthralgia—Epirubicin—liver cancer	0.00376	0.00386	CcSEcCtD
Cefadroxil—Vertigo—Doxorubicin—liver cancer	0.00367	0.00377	CcSEcCtD
Cefadroxil—Anaphylactic shock—Epirubicin—liver cancer	0.0036	0.0037	CcSEcCtD
Cefadroxil—Convulsion—Doxorubicin—liver cancer	0.00354	0.00363	CcSEcCtD
Cefadroxil—Thrombocytopenia—Epirubicin—liver cancer	0.00353	0.00362	CcSEcCtD
Cefadroxil—Arthralgia—Doxorubicin—liver cancer	0.00348	0.00357	CcSEcCtD
Cefadroxil—Cefoperazone—ALB—liver cancer	0.0034	0.131	CrCbGaD
Cefadroxil—Anaphylactic shock—Doxorubicin—liver cancer	0.00333	0.00342	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00328	0.00337	CcSEcCtD
Cefadroxil—Thrombocytopenia—Doxorubicin—liver cancer	0.00326	0.00335	CcSEcCtD
Cefadroxil—Somnolence—Epirubicin—liver cancer	0.0032	0.00329	CcSEcCtD
Cefadroxil—Dyspepsia—Epirubicin—liver cancer	0.00317	0.00326	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Epirubicin—liver cancer	0.00311	0.00319	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00304	0.00312	CcSEcCtD
Cefadroxil—Somnolence—Doxorubicin—liver cancer	0.00296	0.00304	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Epirubicin—liver cancer	0.00295	0.00303	CcSEcCtD
Cefadroxil—Dyspepsia—Doxorubicin—liver cancer	0.00294	0.00301	CcSEcCtD
Cefadroxil—Ampicillin—ALB—liver cancer	0.00289	0.112	CrCbGaD
Cefadroxil—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00288	0.00296	CcSEcCtD
Cefadroxil—Urticaria—Epirubicin—liver cancer	0.00286	0.00294	CcSEcCtD
Cefadroxil—Abdominal pain—Epirubicin—liver cancer	0.00285	0.00292	CcSEcCtD
Cefadroxil—Body temperature increased—Epirubicin—liver cancer	0.00285	0.00292	CcSEcCtD
Cefadroxil—Cefazolin—ALB—liver cancer	0.00279	0.108	CrCbGaD
Cefadroxil—Gastrointestinal pain—Doxorubicin—liver cancer	0.00273	0.0028	CcSEcCtD
Cefadroxil—Hypersensitivity—Epirubicin—liver cancer	0.00266	0.00273	CcSEcCtD
Cefadroxil—Urticaria—Doxorubicin—liver cancer	0.00265	0.00272	CcSEcCtD
Cefadroxil—Body temperature increased—Doxorubicin—liver cancer	0.00264	0.00271	CcSEcCtD
Cefadroxil—Abdominal pain—Doxorubicin—liver cancer	0.00264	0.00271	CcSEcCtD
Cefadroxil—Asthenia—Epirubicin—liver cancer	0.00259	0.00265	CcSEcCtD
Cefadroxil—Pruritus—Epirubicin—liver cancer	0.00255	0.00262	CcSEcCtD
Cefadroxil—Diarrhoea—Epirubicin—liver cancer	0.00247	0.00253	CcSEcCtD
Cefadroxil—Hypersensitivity—Doxorubicin—liver cancer	0.00246	0.00252	CcSEcCtD
Cefadroxil—Asthenia—Doxorubicin—liver cancer	0.00239	0.00246	CcSEcCtD
Cefadroxil—Dizziness—Epirubicin—liver cancer	0.00238	0.00245	CcSEcCtD
Cefadroxil—Pruritus—Doxorubicin—liver cancer	0.00236	0.00242	CcSEcCtD
Cefadroxil—Cefalotin—ALB—liver cancer	0.00232	0.0896	CrCbGaD
Cefadroxil—Vomiting—Epirubicin—liver cancer	0.00229	0.00235	CcSEcCtD
Cefadroxil—Diarrhoea—Doxorubicin—liver cancer	0.00228	0.00234	CcSEcCtD
Cefadroxil—Rash—Epirubicin—liver cancer	0.00227	0.00233	CcSEcCtD
Cefadroxil—Dermatitis—Epirubicin—liver cancer	0.00227	0.00233	CcSEcCtD
Cefadroxil—Headache—Epirubicin—liver cancer	0.00226	0.00232	CcSEcCtD
Cefadroxil—Dizziness—Doxorubicin—liver cancer	0.00221	0.00226	CcSEcCtD
Cefadroxil—Nausea—Epirubicin—liver cancer	0.00214	0.0022	CcSEcCtD
Cefadroxil—Vomiting—Doxorubicin—liver cancer	0.00212	0.00218	CcSEcCtD
Cefadroxil—Cephalexin—ALB—liver cancer	0.00211	0.0814	CrCbGaD
Cefadroxil—Rash—Doxorubicin—liver cancer	0.0021	0.00216	CcSEcCtD
Cefadroxil—Dermatitis—Doxorubicin—liver cancer	0.0021	0.00216	CcSEcCtD
Cefadroxil—Headache—Doxorubicin—liver cancer	0.00209	0.00214	CcSEcCtD
Cefadroxil—Nausea—Doxorubicin—liver cancer	0.00198	0.00203	CcSEcCtD
